BioMarker Strategies is a privately held molecular diagnostics company founded in 2006 at The Johns Hopkins Science & Technology Park in Baltimore, and now based in Rockville, Maryland. Our mission is to help make personalized medicine more of a reality for patients with solid tumor cancers, by providing powerful new molecular tools and research services to guide targeted drug development and treatment selection for these patients.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
SnapPath Cancer Diagnostics System
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):